首页> 美国卫生研究院文献>Cancer Science >Genetic and Epigenetic Resistance of SL/Ni Mice to Lymphomas
【2h】

Genetic and Epigenetic Resistance of SL/Ni Mice to Lymphomas

机译:SL / Ni小鼠对淋巴瘤的遗传和表观遗传抗性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The murine spontaneous B lymphoma is etiologically related to the expression of endogenous ecotropic marine leukemia virus (ETV). Although both SL/Kh and SL/Ni mouse strains show a high level of expression of ETV from early in life, the former is a pre‐B lymphoma‐prone strain and the latter is rather lymphoma‐resistant. In order to identify the host background difference related to the lymphomagenesis, we performed a genetic cross study between these two strains. In the reciprocal F1 generation, the length of the lymphoma latent period was slightly but significantly longer in (SL/Ni XSL/Kh)F1 than in (SL/Kh × SL/Ni)F1 (P<0.05). The incidence of overall lymphomas and that of acute pre‐B lymphomas was lower in (SL/Ni × SL/Kh)F1 than in (SL/Kh × SL/Ni)F1, although the difference was not statistically significant. These observations indicate that an epigenetic maternal resistance mechanism of SL/Ni mice plays a role in the lymphoma resistance. Furthermore, in the backcross combinations without maternal influence of SL/Ni, we observed a genetic mechanism of lymphoma resistance: an SL/Ni‐derived recessive lymphoma‐resistance gene mapped in the proximal segment of Chr. 4. We named this gene nir‐1 (SL/Ni‐lymphoma resistance‐1). Thus, we have demonstrated epigenetic and genetic mechanisms of lymphoma resistance of the SL/Ni mouse with the high expression of endogenous ETV.
机译:鼠自发性B淋巴瘤在病因上与内源性嗜生性海洋白血病病毒(ETV)的表达有关。尽管SL / Kh和SL / Ni小鼠品系从一开始就显示ETV的高水平表达,但前者是易B前淋巴瘤的品系,而后者是相当耐淋巴瘤的。为了鉴定与淋巴瘤发生有关的宿主背景差异,我们在这两个菌株之间进行了遗传交叉研究。在倒数F1代中,(SL / Ni XSL / Kh)F1的淋巴瘤潜伏期的长度略长于(SL / Kh×SL / Ni)F1的淋巴瘤潜伏期的长度(P <0.05)。 (SL / Ni×SL / Kh)F1的整体淋巴瘤和急性B前淋巴瘤的发生率低于(SL / Kh×SL / Ni)F1,尽管差异无统计学意义。这些观察结果表明SL / Ni小鼠的表观遗传的母体抵抗机制在淋巴瘤抵抗中起作用。此外,在没有SL / Ni母体影响的回交组合中,我们观察到了淋巴瘤耐药性的遗传机制:位于Chr近端的SL / Ni衍生的隐性淋巴瘤耐药基因。 4.我们将该基因命名为nir-1(SL / Ni-淋巴瘤耐药性-1)。因此,我们证明了内源ETV高表达的SL / Ni小鼠淋巴瘤耐药性的表观遗传和遗传机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号